We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Guidance on the safe and effective use of GLP-1 medicines for weight loss and diabetes.
You may need to tell DVLA if you have diabetes, depending on the treatment you're getting
As with any medicine, the MHRA will keep the safety and effectiveness of teplizumab under close review.
Advice for medical professionals to follow when assessing drivers with diabetes mellitus.
This report is the latest in a series of publications on diabetes by NHS Digital. It covers the period 2008/09 to 2018/19.
Understanding gut microbiome interactions with medicines could help explain differences in how people respond to treatment and build on existing medicine safety knowledge to support safer, more effective prescribing in the future.
Essential advice on protecting your medicines during extreme heat and staying safe this summer.
Do not include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).